Skip to main content
Fig. 1 | BMC Bioinformatics

Fig. 1

From: Comparison of different statistical approaches for urinary peptide biomarker detection in the context of coronary artery disease

Fig. 1

Study design for biomarker identification and validation. CADD, coronary artery disease diagnosis; AMIP, acute myocardial infarction prognostication; ACD, combined coronary artery disease diagnosis and outcome (AMI) prognostication; WT, non-parametric Wilcoxon rank sum test, BDA, binary discriminant analysis; RF, random forests; SVM, support vector machine; DDA, diagonal discriminant analysis; LDA, linear discriminant analysis

Back to article page